by 
The ambulatory infusion center provides convenient outpatient services for chronic disease patients needing ongoing intravenous therapies or infusions. Patients receive treatments by visiting ambulatory infusion centers rather than staying admitted in hospitals. This allows patients to continue their daily activities and routines while undergoing necessary IV therapies for long term management of diseases such as Crohn’s disease, Multiple sclerosis, Cancer, Rheumatoid arthritis etc. The advantages of ambulatory infusion centers include reduced hospital visits and stays, individualized treatment plans as per patient convenience, and cost savings for patients opting out of extended inpatient admissions. The global ambulatory infusion center market is estimated to be valued at US$67.84 Billion in 2024 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends: One of the key trends in the ambulatory infusion center market is the increasing adoption of portable infusion devices. Portable infusion pumps have enabled effective outpatient treatment delivery and better management of chronic diseases from home care settings. This has further boosted the demand for ambulatory infusion centers providing infusion therapies with portable pumps in an outpatient setup. Being lightweight and easy to carry, these infusion pumps can administer IV drugs and medications on the go, avoiding dependency on hospital visits. Their rising popularity is significantly contributing to the growth of ambulatory infusion centers market globally.
Porter’s Analysis
Threat of new entrants: Low, as there are high costs involved in setting up infrastructure and complying with strict medical regulations required in such centers.
Bargaining power of buyers: Moderate, as major buyers are insurance providers and they can negotiate on pricing and service quality.
Bargaining power of suppliers: Low, as there are many medical equipment and drug suppliers in the market.
Threat of new substitutes: Low, as there aren’t many alternatives available for ambulatory infusion services required for medical conditions.
Competitive rivalry: High, as existing players compete on service quality, reliability, technology and pricing.
Key Takeaways
The global Ambulatory Infusion Center market is expected to witness high growth. Being a relatively new concept, ambulatory infusion centers are gaining traction due to benefits like low costs and reduced stay of patients.
Regional analysis – North America accounts for the largest share in the global ambulatory infusion center market and the trend is expected to continue during the forecast period. However, Asia Pacific is anticipated to witness the highest growth rate during the forecast period on account of higher investments in healthcare infrastructure and increasing focus of key players towards emerging markets.
Key players – Key players operating in the ambulatory infusion center market are Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health, and PharMerica. Option Care Health and Coram CVS are two of the largest players offering vast service portfolios and infrastructure to patients.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
